0001127602-14-019995.txt : 20140624 0001127602-14-019995.hdr.sgml : 20140624 20140605151127 ACCESSION NUMBER: 0001127602-14-019995 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140603 FILED AS OF DATE: 20140605 DATE AS OF CHANGE: 20140605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUBIST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000912183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223192085 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-8660 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOULDER LEON O JR CENTRAL INDEX KEY: 0001228865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36151 FILM NUMBER: 14893486 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-06-03 0000912183 CUBIST PHARMACEUTICALS INC CBST 0001228865 MOULDER LEON O JR 65 HAYDEN AVENUE LEXINGTON MA 02421 1 Common Stock 2014-06-03 4 A 0 899 0 A 9997 D Common Stock 2014-06-03 4 M 0 1104 0 A 11101 D Stock Options (Right to Buy) 66.68 2014-06-03 4 A 0 6202 0 A 2015-06-03 2024-06-03 Common Stock 6202 6202 D Restricted Stock Units 0 2014-06-03 4 A 0 1687 0 A 2015-06-03 Common Stock 1687 1687 D Restricted Stock Units 2014-06-03 4 M 0 1104 0 D 2014-06-03 Common Stock 1104 0 D The Reporting Person elected to receive the entire amount of his/her annual retainer for service as a Director in common stock. The shares of common stock reported in the table respresents the shares of common stock issued to the Reporting Person for the annual retainer that was payable to the Reporting Person as of the Issuer's June 3, 2014 Annual Meeting of Stockholders. The number of stock options is equal to the fair value of $112,500 calculated using the Black-Scholes option-pricing model in accordance with ASC Topic 718. Options vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2015 Annual Meeting of Stockholders. Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration. The number of restricted stock units is equal to the fair value of $112,500 calculated using the Black-Scholes option-pricing model in accordance with ASC Topic 718. The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2015 Annual Meeting of Stockholders. The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2015 Annual Meeting of Stockholders. The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2014 Annual Meeting of Stockholders. /s/ Joseph L. Farmer - Attorney in fact 2014-06-05 EX-24 2 doc1.htm POWER OF ATTORNEY Leon Moulder POA

EXHIBIT 24

Cubist Pharmaceuticals Inc

Power of Attorney
for Executing Forms 3, 4 and 5

Know all men by these presents, that the undersigned, director or officer, or both, of Cubist Pharmaceuticals Inc, hereby constitutes and appoints each of Michael W. Bonney, Joseph L. Farmer, and Michasel J. Tomsicek, signing singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Cubist Pharmaceuticals Inc (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities of Cubist Pharmaceuticals Inc unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of this 7th day of March, 2013
/s/ Leon Moulder
Leon Moulder